Pilot Study of Dapansutrile Capsules in Schnitzler's Syndrome

Stopped The study was terminated due to study design issues that did not allow for determination of efficacy and safety in subjects with Schnitzler Syndrome who are currently well controlled on anakinra therapy.

Conditions

• Schnitzler Syndrome

Interventions

• DRUG: dapansutrile

Sponsor

Olatec Therapeutics LLC

Collaborators

• [object Object]